Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $76.5 million.

  • Bio-Techne's Free Cash Flow fell 133.51% to $76.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $223.0 million, marking a year-over-year decrease of 1230.15%. This contributed to the annual value of $256.6 million for FY2025, which is 865.97% up from last year.
  • Bio-Techne's Free Cash Flow amounted to $76.5 million in Q4 2025, which was down 133.51% from $22.2 million recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Free Cash Flow ranged from a high of $110.7 million in Q2 2021 and a low of $22.2 million during Q3 2025
  • For the 5-year period, Bio-Techne's Free Cash Flow averaged around $63.1 million, with its median value being $61.3 million (2021).
  • In the last 5 years, Bio-Techne's Free Cash Flow soared by 30376.4% in 2021 and then crashed by 5938.74% in 2025.
  • Over the past 5 years, Bio-Techne's Free Cash Flow (Quarter) stood at $90.8 million in 2021, then crashed by 35.84% to $58.3 million in 2022, then grew by 17.12% to $68.3 million in 2023, then increased by 13.59% to $77.5 million in 2024, then decreased by 1.34% to $76.5 million in 2025.
  • Its Free Cash Flow was $76.5 million in Q4 2025, compared to $22.2 million in Q3 2025 and $93.3 million in Q2 2025.